178 related articles for article (PubMed ID: 10321426)
1. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan.
Bunt T
Clin Ther; 1999 Mar; 21(3):611-2. PubMed ID: 10321426
[No Abstract] [Full Text] [Related]
2. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators.
Oparil S; Guthrie R; Lewin AJ; Marbury T; Reilly K; Triscari J; Witcher JA
Clin Ther; 1998; 20(3):398-409. PubMed ID: 9663357
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators.
Kassler-Taub K; Littlejohn T; Elliott W; Ruddy T; Adler E
Am J Hypertens; 1998 Apr; 11(4 Pt 1):445-53. PubMed ID: 9607383
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin receptor blockers -- finally the evidence is coming in: IDNT and RENAAL.
Coats AJ
Int J Cardiol; 2001 Jul; 79(2-3):99-102. PubMed ID: 11461726
[No Abstract] [Full Text] [Related]
5. Problems with interpreting the data in Kassler-Taub et al's article comparing irbesartan and losartan.
Bunt T
Am J Hypertens; 1999 Jan; 12(1 Pt 1):79-81. PubMed ID: 10075390
[No Abstract] [Full Text] [Related]
6. Angiotensin receptor blockers in essential hypertension.
Brown MJ
Lancet; 1993 Dec; 342(8884):1374-5. PubMed ID: 7901674
[No Abstract] [Full Text] [Related]
7. Angiotensin II receptor blockers and nephropathy trials.
Bloomgarden ZT
Diabetes Care; 2001 Oct; 24(10):1834-8. PubMed ID: 11574450
[No Abstract] [Full Text] [Related]
8. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout.
Liberopoulos E; Christides D; Elisaf M
J Hypertens; 2002 Feb; 20(2):347. PubMed ID: 11821722
[No Abstract] [Full Text] [Related]
9. AT1-receptor blockers.
Petkun W
Eur Heart J; 2000 Feb; 21(4):335-7. PubMed ID: 10653684
[No Abstract] [Full Text] [Related]
10. [The medicine of the month. Losartan (Cozaar)].
Scheen AJ
Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640
[No Abstract] [Full Text] [Related]
11. Irbesartan treatment in hypertension.
Brown MJ
Hosp Med; 1998 Oct; 59(10):808-11. PubMed ID: 9850301
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy-safety relationship of AT1 angiotensin II receptor antagonists: current data].
Paoletti V; Di Veroli C; Pugliese M; Cammarella I; Cavina G; Turchetti P; Mammarella A
Clin Ter; 2002; 153(1):61-4. PubMed ID: 11963637
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor antagonists.
Goldsmith DJ
Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
[No Abstract] [Full Text] [Related]
14. Examining the association of olmesartan and other angiotensin receptor blockers with overall and cause-specific mortality.
Lin JW; Chang CH; Caffrey JL; Wu LC; Lai MS
Hypertension; 2014 May; 63(5):968-76. PubMed ID: 24516110
[TBL] [Abstract][Full Text] [Related]
15. A population-based European cohort study of persistence in newly diagnosed hypertensive patients.
Hasford J; Mimran A; Simons WR
J Hum Hypertens; 2002 Aug; 16(8):569-75. PubMed ID: 12149663
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertension.
Andersson OK; Neldam S
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S63-4. PubMed ID: 9331011
[No Abstract] [Full Text] [Related]
17. A new class of antihypertensive: angiotensin II receptor antagonists.
McCoy R
S D J Med; 1995 Sep; 48(9):319-20. PubMed ID: 7481726
[No Abstract] [Full Text] [Related]
18. Losartan: the first angiotensin receptor antagonist in clinical use.
Beevers DG
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475
[No Abstract] [Full Text] [Related]
19. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
[TBL] [Abstract][Full Text] [Related]
20. AT1-receptor antagonists for the treatment of chronic heart failure.
Baan J
Cardiovasc Res; 1999 Jan; 41(1):14-5. PubMed ID: 10325947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
